IL9 and arthritic joint disease: A recent elegant paper led by Rauber 116 showed that RA patients in remission had increased ILC2 producing IL‐9 in circulation and synovium, and that ILC2/IL‐9 fostered the resolution of inflammation and restored joint immune‐homeostasis in experimental arthritis models 116.